Neal Patel

Neal Patel is a dynamic entrepreneur and healthcare strategist with a proven ability to build, scale, and optimize businesses from the ground up. With a deep understanding of the regulatory and commercial landscapes, he has spent the last decade executing high-growth strategies in life sciences, clinical research, and healthcare technology, leveraging his expertise to drive both financial success and clinical impact.

Neal know how to integrate fragmented specialties in medicine to create scalable, high-value solutions. His ability to connect disparate stakeholders—pharmaceutical companies, physicians, and payors—into cohesive, high-functioning ecosystems has enabled the development of innovative business models that unlock new revenue streams, optimize healthcare delivery, and drive medical advancements.

As the founder of one of the fastest-growing clinical research networks in the U.S., he demonstrated an innate ability to architect and operationalize companies without reliance on institutional capital. His strategic foresight led the company to rapid multi-specialty expansion, successfully bridging Nephrology, Complex Metabolic, Infectious Disease, and Behavioral Health into a unified platform that maximized both clinical efficiency and commercial scalability.

Currently, Neal is leading the strategy for an ambitious initiative to integrate real-world evidence (RWE) into infectious disease management, designing the first comprehensive, user-agnostic data registry to capture longitudinal patient insights. This platform is set to transform how pharma, healthcare providers, and payors interact with real-world data, addressing billions in inefficiencies while enhancing treatment outcomes and reducing unnecessary costs.

With an exceptional ability to identify opportunities, execute at scale, and navigate complex regulatory environments, Neal is redefining how healthcare businesses are built, scaled, and optimized. His relentless focus on efficiency, innovation, and impact positions him as a leader in transforming fragmented industries into cohesive, high-performing enterprises that deliver measurable value both financially and clinically.